Puma Biotechnology, Inc.PBYINASDAQ
Loading
Operating Income Growth Recovery in ProgressRecovering
Percentile Rank57
3Y CAGR-77.3%
5Y CAGR-19.3%
Year-over-Year Change
Year-over-year operating income growth rate
3Y CAGR
-77.3%/yr
vs +125.2%/yr prior
5Y CAGR
-19.3%/yr
Recent deceleration
Acceleration
-202.4pp
Decelerating
Percentile
P57
Within normal range
vs 5Y Ago
0.3x
Contraction
Streak
1 yr
Consecutive growthRecovering
| Period | Value |
|---|---|
| 2025 | 20.45% |
| 2024 | -5.13% |
| 2023 | 37.61% |
| 2022 | 1738.76% |
| 2021 | 104.24% |
| 2020 | 59.78% |
| 2019 | 20.17% |
| 2018 | 67.61% |
| 2017 | -5.71% |
| 2016 | -15.11% |